We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$826M
AUM Growth
Cap. Flow
+$577M
Cap. Flow %
69.85%
Top 10 Hldgs %
23.05%
Holding
4,682
New
4,618
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$33M
2
AAPL icon
Apple
AAPL
+$32.5M
3
BKNG icon
Booking.com
BKNG
+$28.7M
4
AMZN icon
Amazon
AMZN
+$25.7M
5
BIDU icon
Baidu
BIDU
+$16.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.8%
2 Technology 11.13%
3 Healthcare 8.34%
4 Energy 5.42%
5 Communication Services 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIG icon
1901
CEMIG Preferred Shares
CIG
$6.09B
$21K ﹤0.01%
+8,210
New +$23.3K
CME icon
1902
PUT
CME Group
CME
$92.2B
$21K ﹤0.01%
+192
New +$16.3K
CNX icon
1903
PUT
CNX Resources
CNX
$4.85B
$21K ﹤0.01%
+73
New +$2.21K
COO icon
1904
CALL
Cooper Companies
COO
$13.7B
$21K ﹤0.01%
+332
New +$13.3K
CPA icon
1905
CALL
Copa Holdings
CPA
$5.56B
$21K ﹤0.01%
+115
New +$12.2K
ED icon
1906
PUT
Consolidated Edison
ED
$41.6B
$21K ﹤0.01%
+184
New +$11.5K
FE icon
1907
PUT
FirstEnergy
FE
$28.9B
$21K ﹤0.01%
+325
New +$11.9K
FRO icon
1908
CALL
Frontline
FRO
$8.75B
$21K ﹤0.01%
+27
New +$220
GMED icon
1909
Globus Medical
GMED
$10.4B
$21K ﹤0.01%
+871
New +$19.3K
HE icon
1910
CALL
Hawaiian Electric Industries
HE
$2.33B
$21K ﹤0.01%
+39
New +$1.14K
INO icon
1911
CALL
Inovio Pharmaceuticals
INO
$79.8M
$21K ﹤0.01%
+8
New +$978
IQV icon
1912
CALL
IQVIA
IQV
$34.7B
$21K ﹤0.01%
+28
New +$1.6K
ITUB icon
1913
Itaú Unibanco
ITUB
$91.3B
$21K ﹤0.01%
+3,981
New +$22.4K
MHK icon
1914
PUT
Mohawk Industries
MHK
$6.9B
$21K ﹤0.01%
+45
New +$6.47K
NBIX icon
1915
PUT
Neurocrine Biosciences
NBIX
$17.7B
$21K ﹤0.01%
+191
New +$3.62K
NDAQ icon
1916
Nasdaq
NDAQ
$51.5B
$21K ﹤0.01%
+1,305
New +$19.2K
NTAP icon
1917
CALL
NetApp
NTAP
$32.9B
$21K ﹤0.01%
+95
New +$3.94K
NTRS icon
1918
PUT
Northern Trust
NTRS
$22.2B
$21K ﹤0.01%
+49
New +$3.26K
PH icon
1919
CALL
Parker-Hannifin
PH
$125B
$21K ﹤0.01%
+36
New +$4.42K
SKM icon
1920
SK Telecom
SKM
$13.7B
$21K ﹤0.01%
+467
New +$21.7K
SPH icon
1921
PUT
Suburban Propane Partners
SPH
$1.23B
$21K ﹤0.01%
+50
New +$2.22K
SUPN icon
1922
CALL
Supernus Pharmaceuticals
SUPN
$2.68B
$21K ﹤0.01%
+160
New +$1.34K
SWK icon
1923
CALL
Stanley Black & Decker
SWK
$14.2B
$21K ﹤0.01%
+77
New +$7.1K
TS icon
1924
PUT
Tenaris
TS
$29.1B
$21K ﹤0.01%
+14
New +$500
UL icon
1925
PUT
Unilever
UL
$131B
$21K ﹤0.01%
+41
New +$1.88K

Similar funds

Simplex Trading's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Simplex Trading, which disclosed 4,682 positions worth $826M. Its ten largest holdings account for 23% of the portfolio.

Its largest position is Gilead Sciences: 319,426 shares worth $30.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, followed by Technology and Healthcare.

  • Simplex Trading's largest Q4 2014 buy was Gilead Sciences: 319,426 shares worth $30.1M.
  • Simplex Trading's ten largest holdings make up 23% of its $826M portfolio in Q4 2014.
  • Simplex Trading disclosed 4,682 positions in Q4 2014, its first 13F filing on record.

Based on Simplex Trading's 13F filing for Q4 2014, filed 4 Mar 2015.